1. Watermelon and l-Citrulline in Cardio-Metabolic Health: Review of the Evidence 2000–2020

   • Britt Burton-Freeman
   • Morganne Freeman
   • Indika Edirisinghe

   Nutrition (K. Petersen, Section Editor) 11 December 2021 Article: 81

   

2. Statins and Inflammation

   • Martin Satny
   • Jaroslav A. Hubacek
   • Michal Vrablik

   Statin Drugs (R. Ceska, Section Editor) 01 December 2021 Article: 80

3. Monoclonal Antibodies in the Management of Familial Hypercholesterolemia: Focus on PCSK9 and ANGPTL3 Inhibitors

   • Angela Pirillo
   • Alberico L. Catapano
   • Giuseppe D. Norata

   Nonstatin Drugs (M. Vrablik, Section Editor) Open access 26 October 2021 Article: 79

   

4. Moving the Needle on Atherosclerotic Cardiovascular Disease and Heart Failure with Influenza Vaccination

   • Bahar Behrouzi
   • Jacob A. Udell

   Cardiovascular Disease and Stroke (J. A. Underberg and J. Newman, Section Editors) 21 October 2021 Article: 78

   

5. Differences in the 2020 ESC Versus 2015 ESC and 2014 ACC/AHA Guidelines on the Management of Acute Coronary Syndromes in Patients Presenting Without Persistent ST-Segment Elevation

   • Mohammad Keykhaei
   • Haleh Ashraf
   • Stefan James

   Evidence-Based Medicine, Clinical Trials and Their Interpretations (K. Nasir, Section Editor) 21 October 2021 Article: 77

   

6. Highlights of Cardiovascular Disease Studies Presented at the 2021 European Society of Cardiology Congress

   • Michelle T. Lee
   • Dhruv Mahtta
   • Salim S. Virani

   Reviews and New Research Implications (S. Virani, Section Editor) 14 October 2021 Article: 76

7. Gene-Environment Interactions for Cardiovascular Disease

   • Jaana A. Hartiala
   • James R. Hilser
   • Hooman Allayee

   Genetics and Genomics (A. Marian, Section Editor) 14 October 2021 Article: 75

   

8. Oral Lipid-Lowering Treatments Beyond Statins: Too Old and Outdated or Still Useful?

   • Klaus G. Parhofer

   Nonstatin Drugs (M. Vrablik, Section Editor) Open access 14 October 2021 Article: 74